• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMÉRIEUX SA ETEST® VANCOMYCIN (VA); VANCOMYCIN VA 256 WW S30

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMÉRIEUX SA ETEST® VANCOMYCIN (VA); VANCOMYCIN VA 256 WW S30 Back to Search Results
Model Number 412488
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
Intended use: etest® is a manual, quantitative technique for the determination of antimicrobial susceptibility of non-fastidious gram-negative and gram-positive aerobic bacteria and fastidious bacteria.The system comprises a predefined antibiotic gradient which is used to determine the minimum inhibitory concentration (mic, in g/ml) of different antimicrobial agents against microorganisms tested on agar media after overnight incubation.Issue description: a publication in spain reported a high rate of false susceptible vancomycin results for vancomycin-resistant enterococcus species associated with vancomycin va 256 ww s30 (ref.(b)(4), lot unknown).At the time of assessment, there is no indication or report from the customer that this event led to any adverse event related to any patient's state of health.Although vancomycin va 256 ww s30 - (b)(4) is not registered in the united states, a similar product vancomycin va 256 us s30-412486 is registered in the united states.
 
Manufacturer Narrative
This investigation was initiated following post market surveillance (pms), article (b)(4), related to the etest products vancomycin (va 256) and teicoplanin (tp 256).This article described a high percentage of discrepant minimum inhibitory concentration (mic) results especially for vancomycin (2% of mics discrepancies) and teicoplanin (9,2% of mics discrepancies) with vanb phenotype enterococcus faecium isolates.This study seems to highlight an underestimation of mic values with the two etest products mentioned above.Within the pms process, it was concluded that, based on this article, a further investigation should be done.To further investigate the article, the strains used during the study were necessary to perform in-house tests.Despite numerous attempts with the customer, we were unable to retrieve the requested strains.Thereby, no test can be performed at biomérieux.Trend analysis: on the 18th of october 2023, a complaint trend analysis was performed since 2021 on the etest products va 256 and tp 256.No trend related to performance issue and particularly related to mics underestimation was observed.Conclusion: as no strains were submitted, it was not possible to investigate further, nor to identify any root cause for the issue described in this article.No negative trend is detected for etest products va 256 and tp 256.As it was not possible to confirm any performance gap during this investigation for etest products va 256 and tp 256, neither corrective nor preventive action will be implemented.
 
Event Description
Intended use: etest® is a manual, quantitative technique for the determination of antimicrobial susceptibility of non-fastidious gram-negative and gram-positive aerobic bacteria and fastidious bacteria.The system comprises a predefined antibiotic gradient which is used to determine the minimum inhibitory concentration (mic, in ¿g/ml) of different antimicrobial agents against microorganisms tested on agar media after overnight incubation.Issue description: a publication in spain reported a high rate of false susceptible vancomycin results for vancomycin-resistant enterococcus species associated with vancomycin va 256 ww s30 (ref.412488, lot unknown).At the time of assessment, there is no indication or report from the customer that this event led to any adverse event related to any patient's state of health.Note: although vancomycin va 256 ww s30 - 412488 is not registered in the united states, a similar product vancomycin va 256 us s30-412486 is registered in the united states.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ETEST® VANCOMYCIN (VA)
Type of Device
VANCOMYCIN VA 256 WW S30
Manufacturer (Section D)
BIOMÉRIEUX SA
3, route de port michaud
la balme 38390
FR  38390
Manufacturer (Section G)
BIOMÉRIEUX SA
3, route de port michaud
la balme 38390
FR   38390
Manufacturer Contact
matthew locus
595 anglum road
hazelwood, MO 63042
MDR Report Key16241825
MDR Text Key308202466
Report Number9615754-2023-00003
Device Sequence Number1
Product Code JWY
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K980348
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 01/31/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/25/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number412488
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/30/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-